BioStone Scientific Launches AsurPure™ BHBA and NEFA Enzymatic Assay Kits for Dairy Cattle Metabolic Biomarker Testing

DALLAS-FORT WORTH, TX — June 26, 2026 — BioStone Scientific has launched two new AsurPure™ enzymatic assay kits for metabolic biomarker testing in bovine serum: the AsurPure™ β-Hydroxybutyrate (BHBA) Enzymatic Assay Kit and the AsurPure™ Non-Esterified Fatty Acids (NEFA) Enzymatic Assay Kit. These laboratory-based tools are designed to support quantitative measurement of key metabolic biomarkers…

BioStone Animal Health Launches AsurDx™ Hantavirus (HTNV) Real-Time RT-PCR Detection Kit

Dallas – Forth Worth, TX — May 21, 2026  — BioStone Animal Health LLC proudly announces the launch of the AsurDx™ Hantavirus (HTNV) Real-Time RT-PCR Detection Kit (HTNV 2050-RT), a highly sensitive molecular diagnostic assay designed for the rapid detection of Hantavirus RNA in clinical and research samples. The AsurDx™ Hantavirus PCR kit utilizes advanced one-step fluorescent real-time…

BioStone AsurDx™ iELISA for African Swine Fever Evaluated by FLI ASF Reference Laboratory and Published in Pathogens

Dallas – Forth Worth, TX — May 12, 2026  — BioStone Animal Health is pleased to announce that the AsurDx™ African Swine Fever Virus (ASFV) Antibody Indirect ELISA (iELISA) has been independently evaluated by the Friedrich-Loeffler-Institut (FLI), Germany’s National Reference Laboratory for African Swine Fever (ASF), with the study results published in the peer-reviewed scientific journal Pathogens. The…

BioStone Animal Health Acquires American Animal Health Assets, Expands USDA-Licensed Autogenous Bacterin Manufacturing Capabilities

Southlake, TX / Grand Prairie, TX — February 23, 2026  — BioStone Animal Health announced today that it has acquired the business assets of American Animal Health, Inc. (AAH), including AAH’s USDA-licensed manufacturing facility in Grand Prairie, Texas (Est. 315). The acquisition strengthens BioStone’s ability to serve veterinarians and producers with high-quality, herd-specific autogenous bacterins supported by established manufacturing…

BioStone Animal Health Advances Nipah Virus Antibody Surveillance with Multi-Species iELISA

DALLAS-FORT WORTH, TX — January 29, 2026  — In response to the recent Nipah virus (NiV) outbreak reported in India, BioStone Animal Health has launched a multi-species indirect ELISA (iELISA) Test kit for Nipah virus antibody detection (Cat. 10101), designed to support surveillance, biosecurity, and outbreak preparedness. Nipah virus is a highly pathogenic zoonotic virus with recurrent outbreaks…

BioStone Animal Health Launches CL (Caseous Lymphadenitis, Corynebacterium pseudotuberculosis) Antibody ELISA Test Kit

DALLAS-FORT WORTH, TX— January 26, 2026 — BioStone Animal Health is pleased to announce the launch of the AsurDx™ Caseous Lymphadenitis (Corynebacterium pseudotuberculosis) Antibody ELISA Test Kit, designed for the detection of antibodies specific to Corynebacterium pseudotuberculosis in goat and sheep serum or plasma samples. About AsurDx™ CL Antibody ELISA Test Kit The AsurDx™ Caseous Lymphadenitis Antibody…

BioStone Animal Health Launches Trypanosoma Cruzi (Causative Agent of Chagas Disease) PCR Test Kit

DALLAS-FORT WORTH, TX— November 21, 2025 — BioStone Animal Health is pleased to announce the launch of the AsurDxTM Trypanosoma Cruzi Real-Time PCR Detection Kit designed for the detection of Trypanosoma Cruzi (causative agent of Chagas Disease) in dog whole blood and feces. About Trypanosoma cruzi and Chagas Disease Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious and potentially…

BioStone Animal Health Launches Equine Herpes Virus (EHV) and Equine Viral Arteritis (EVA) ELISA

DALLAS-FORT WORTH, TX— October 3, 2025 — BioStone Animal Health is pleased to announce the launch of two new antibody detection kits designed for the equine market: the AsurDx™ Equine Herpesvirus (EHV) Antibody Test Kit and the AsurDx™ Equine Viral Arteritis (EVA) Antibody Test Kit. These ELISA-based kits provide veterinarians, laboratories, and researchers with rapid, sensitive,…

BioStone Animal Health Launches Real-Time PCR tests for FMD Detection

DALLAS-FORT WORTH, TX— May 30, 2025 — BioStone Animal Health is proud to announce a comprehensive solution for Foot-and-Mouth Disease (FMD) diagnostics with the launch of new real-time (RT) PCR assays. The newly introduced AsurDxTM Real-Time PCR kits include single, dual, and multiplex detection options for : This product line complements BioStone’s existing portfolio of competitive ELISA…